Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2024)Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.
Sectors & IndustriesHealthcare
Sector: Healthcare
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| CYCN | CYCLERION THERAPEUTICS INC | United States | $8.24M | 2,710,096 | 9.83% | 90.17% | Net Buying | |
| TRVI | TREVI THERAPEUTICS INC | United States | $197.23M | 68,960,167 | 22.22% | 77.78% | Net Buying | |
| DTIL | PRECISION BIOSCIENCES INC | United States | $72.48M | 6,916,239 | 53.63% | 46.37% | Net Selling | Net Selling |
| TERN | TERNS PHARMACEUTICALS INC | United States | $328.43M | 64,651,693 | 72.52% | 27.48% | Net Selling | Net Selling |
| LSTA | LISATA THERAPEUTICS INC | United States | $23.70M | 8,307,433 | 0.84% | 99.16% | Net Selling | |
| LFMD | LIFEMD INC | United States | $469.86M | 40,366,047 | 30.83% | 53.11% | Net Buying | |
| SRTS | SENSUS HEALTHCARE INC | United States | $59.18M | 16,394,171 | 15.94% | 32.93% | Net Buying | |
| LABP | LANDOS BIOPHARMA INC | United States | $69.48M | 3,116,729 | 4.53% | 95.47% | ||
| TTNP | TITAN PHARMACEUTICALS INC | United States | $6.13M | 914,234 | 2.50% | 97.50% | Net Selling | |
| BPMC | BLUEPRINT MEDICINES CORP | United States | $5.81B | 61,232,297 | 81.64% | 18.36% | Net Selling | Net Selling |
| ICAD | ICAD INC | United States | $37.95M | 26,540,030 | 24.44% | 62.73% | ||
| CRDF | CARDIFF ONCOLOGY INC | United States | $188.98M | 44,677,169 | 11.85% | 34.59% | Net Buying | |
| RIGL | RIGEL PHARMACEUTICALS INC | United States | $191.16M | 175,377,812 | 60.76% | 15.75% | Net Selling | Net Selling |
| DNTH | DIANTHUS THERAPEUTICS INC | United States | $661.18M | 29,346,760 | 24.91% | 75.09% | Net Buying | |
| TELA | TELA BIO INC | United States | $114.13M | 24,649,595 | 47.74% | 52.26% | Net Selling | Net Selling |
| IRTC | IRHYTHM TECHNOLOGIES INC | United States | $3.46B | 30,978,772 | 77.03% | 22.97% | Net Selling | Net Selling |
| DNA | GINKGO BIOWORKS HOLDINGS INC | United States | $1.81B | 2,152,395,786 | 58.22% | 13.98% | Net Selling | Net Selling |
| LRMR | LARIMAR THERAPEUTICS INC | United States | $468.93M | 63,800,017 | 42.05% | 57.95% | Net Buying | Net Buying |
| CLPT | CLEARPOINT NEURO INC | United States | $146.21M | 26,976,289 | 23.33% | 25.71% | Net Selling | Net Selling |
| PMCB | PHARMACYTE BIOTECH INC | United States | $18.03M | 8,464,824 | 12.86% | 13.29% | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | United States | $1.26B | 49,778,127 | 83.80% | 16.20% | Net Buying | Net Selling |
| NVNO | ENVVENO MEDICAL CORP | United States | $68.32M | 13,317,000 | 27.51% | 72.49% | Net Buying | Net Buying |
| TCRX | TSCAN THERAPEUTICS INC | United States | $412.74M | 47,882,196 | 66.65% | 29.73% | Net Buying | |
| SNSE | SENSEI BIOTHERAPEUTICS INC | United States | $31.59M | 25,070,980 | 11.82% | 71.99% | Net Selling | Net Selling |
| OMIC | SINGULAR GENOMICS SYSTEMS INC | United States | $30.09M | 73,928,557 | 35.41% | 38.17% | Net Selling | |
| TBPH | THERAVANCE BIOPHARMA INC | Cayman Islands | $425.78M | 48,164,708 | 60.28% | 39.72% | Net Selling | Net Selling |
| HOWL | WEREWOLF THERAPEUTICS INC | United States | $257.28M | 42,737,191 | 48.08% | 51.92% | ||
| SDGR | SCHRODINGER INC | United States | $1.84B | 72,679,390 | 77.41% | 22.59% | Net Selling | Net Selling |
| AUGX | AUGMEDIX INC | United States | $123.31M | 48,739,739 | 32.25% | 67.75% | Net Buying | Net Selling |
| NURO | NEUROMETRIX INC | United States | $8.82M | 1,986,540 | 0.64% | 99.36% | Net Buying | Net Selling |
| IOBT | IO BIOTECH INC | Denmark | $102.12M | 65,880,914 | 36.62% | 63.38% | Net Buying | Net Selling |
| ATOS | ATOSSA THERAPEUTICS INC | United States | $191.72M | 125,304,064 | 12.74% | 15.22% | Net Buying | Net Buying |
| BOLT | BOLT BIOTHERAPEUTICS INC | United States | $42.70M | 38,127,740 | 54.74% | 45.26% | Net Selling | |
| RLAY | RELAY THERAPEUTICS INC | United States | $873.65M | 131,179,034 | 72.37% | 27.63% | Net Selling | Net Selling |
| AVXL | ANAVEX LIFE SCIENCES CORP | United States | $303.00M | 82,112,511 | 31.49% | 5.04% | Net Buying | Net Buying |
| CLDX | CELLDEX THERAPEUTICS INC | United States | $2.20B | 55,900,679 | 82.75% | 17.25% | Net Buying | Net Buying |
| ATXS | ASTRIA THERAPEUTICS INC | United States | $521.58M | 54,903,061 | 67.13% | 25.09% | Net Buying | Net Buying |
| PROF | PROFOUND MEDICAL CORP | Canada | $159.21M | 21,370,565 | 43.20% | 0.00% | ||
| ABIO | ARCA BIOPHARMA INC | United States | $47.15M | 14,507,143 | 4.98% | 95.02% | ||
| DMTK | DERMTECH INC | United States | $21.36M | 34,623,443 | 15.75% | 77.74% | Net Selling | Net Selling |
| TVTX | TRAVERE THERAPEUTICS INC | United States | $456.59M | 76,098,485 | 59.75% | 40.25% | Net Selling | Net Selling |
| ETNB | 89BIO INC | United States | $818.14M | 93,501,210 | 85.97% | 14.03% | Net Buying | Net Buying |
| OM | OUTSET MEDICAL INC | United States | $143.94M | 50,505,683 | 85.44% | 14.56% | Net Selling | Net Selling |
| EVGN | EVOGENE LTD | Israel | $36.22M | 50,584,588 | 8.48% | 0.00% | ||
| NEO | NEOGENOMICS INC | United States | $1.78B | 127,711,930 | 72.39% | 27.61% | Net Selling | Net Selling |
| STIM | NEURONETICS INC | United States | $105.78M | 29,756,053 | 50.13% | 49.87% | Net Selling | Net Selling |
| ELVN | ENLIVEN THERAPEUTICS INC | United States | $748.39M | 41,347,632 | 46.22% | 53.78% | Net Selling | Net Selling |
| NRC | NATIONAL RESEARCH CORP | United States | $826.32M | 23,854,428 | 49.73% | 47.81% | Net Selling | Net Selling |
| PULM | PULMATRIX INC | United States | $6.90M | 3,652,285 | 4.28% | 95.72% | ||
| PACS | PACS GROUP INC | United States | N/A | 147,773,386 | 0.00% | 89.85% | Net Selling | Net Selling |
| BYSI | BEYONDSPRING INC | United States | $80.40M | 39,029,163 | 14.01% | 0.00% | ||
| PHAR | PHARMING GROUP NV | Netherlands | $701.27M | 671,073,243 | 0.00% | 0.00% | ||
| DVAX | DYNAVAX TECHNOLOGIES CORP | United States | $1.53B | 130,614,772 | 71.63% | 28.37% | Net Selling | Net Selling |
| RXRX | RECURSION PHARMACEUTICALS INC | United States | $1.96B | 234,653,272 | 75.29% | 24.71% | Net Selling | Net Selling |
| CMAX | CAREMAX INC | United States | $15.06M | 3,802,883 | 49.20% | 50.80% | ||
| OPTN | OPTINOSE INC | United States | $102.29M | 112,651,740 | 69.22% | 30.78% | Net Selling | Net Selling |
| OCUL | OCULAR THERAPEUTIX INC | United States | $746.11M | 148,627,439 | 49.43% | 21.84% | Net Buying | Net Buying |
| NARI | INARI MEDICAL INC | United States | $2.42B | 58,138,159 | 78.21% | 21.79% | Net Selling | Net Selling |
| MNKD | MANNKIND CORP | United States | $1.17B | 270,418,215 | 30.01% | 69.99% | Net Buying | Net Buying |
| URGN | UROGEN PHARMA LTD | Israel | $491.36M | 34,122,087 | 62.74% | 29.32% | Net Buying | Net Selling |
| ICCM | ICECURE MEDICAL LTD | Israel | $53.50M | 45,729,684 | 0.62% | 0.00% | ||
| GTHX | G1 THERAPEUTICS INC | United States | $215.92M | 52,281,391 | 24.14% | 47.00% | Net Selling | Net Selling |
| ECOR | ELECTROCORE INC | United States | $36.26M | 6,002,628 | 7.07% | 92.93% | Net Buying | |
| QIPT | QUIPT HOME MEDICAL CORP | United States | $153.67M | 42,102,000 | 43.00% | 0.00% | ||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | United States | $404.81M | 145,092,271 | 62.07% | 37.93% | Net Selling | Net Selling |
| FOLD | AMICUS THERAPEUTICS INC | United States | $3.08B | 295,382,614 | 66.56% | 33.44% | Net Selling | Net Selling |
| OCGN | OCUGEN INC | United States | $357.68M | 257,325,264 | 10.16% | 11.93% | Net Selling | |
| EXAS | EXACT SCIENCES CORP | United States | $10.89B | 181,530,967 | 88.62% | 3.40% | Net Selling | Net Selling |
| AKYA | AKOYA BIOSCIENCES INC | United States | $194.60M | 49,140,731 | 30.03% | 52.24% | Net Buying | Net Selling |
| RPTX | REPARE THERAPEUTICS INC | Canada | $139.20M | 42,182,177 | 61.13% | 38.87% | Net Buying | Net Selling |
| CANF | CAN-FITE BIOPHARMA LTD | Israel | $8.53M | 1,359,837,393 | 0.02% | 0.00% | ||
| MRNA | MODERNA INC | United States | $42.59B | 382,073,208 | 67.30% | 21.66% | Net Selling | Net Selling |
| BFLY | BUTTERFLY NETWORK INC | United States | $165.83M | 210,707,866 | 37.33% | 43.56% | Net Selling | Net Selling |
| AMWL | AMERICAN WELL CORP | United States | $157.42M | 296,463,116 | 48.64% | 9.56% | Net Selling | Net Selling |
| TCRT | ALAUNOS THERAPEUTICS INC | United States | $20.66M | 16,012,479 | 53.36% | 46.64% | Net Selling | |
| BGLC | BIONEXUS GENE LAB CORP | Malaysia | $10.85M | 17,667,663 | 0.59% | 97.91% | ||
| PNTG | PENNANT GROUP INC | United States | $638.07M | 30,012,588 | 85.43% | 8.92% | Net Buying | Net Buying |
| LNSR | LENSAR INC | United States | $34.98M | 11,395,056 | 32.17% | 48.15% | Net Buying | |
| BLRX | BIOLINERX LTD | Israel | $48.92M | 1,086,589,165 | 0.10% | 0.00% | ||
| TLPH | TALPHERA INC | United States | $16.97M | 16,969,103 | 8.65% | 91.35% | Net Buying | Net Buying |
| AADI | AADI BIOSCIENCE INC | United States | $47.64M | 24,554,205 | 26.93% | 73.07% | Net Selling | Net Selling |
| SILO | SILO PHARMA INC | United States | $5.23M | 2,843,634 | 5.65% | 6.35% | Net Buying | Net Buying |
| BLFS | BIOLIFE SOLUTIONS INC | United States | $791.84M | 45,300,000 | 58.87% | 41.13% | Net Buying | Net Selling |
| SYRA | SYRA HEALTH CORP | United States | $14.66M | 14,064,921 | 0.48% | 4.93% | Net Buying | |
| INVA | INNOVIVA INC | United States | $962.95M | 63,227,333 | 58.68% | 41.32% | Net Buying | Net Buying |
| BRTX | BIORESTORATIVE THERAPIES INC | United States | $9.27M | 6,769,919 | 0.28% | 99.72% | Net Buying | Net Buying |
| STOK | STOKE THERAPEUTICS INC | United States | $535.27M | 46,303,743 | 40.29% | 59.71% | Net Selling | Net Selling |
| IMRN | IMMURON LTD | Australia | $14.12M | 227,798,346 | 0.00% | 0.00% | ||
| HOOK | HOOKIPA PHARMA INC | United States | $88.96M | 98,950,107 | 35.22% | 26.83% | Net Buying | |
| IPHA | INNATE PHARMA SA | France | $204.35M | 80,453,282 | 0.16% | 0.00% | ||
| CLLS | CELLECTIS SA | France | $181.96M | 71,751,201 | 13.68% | 0.00% | ||
| EVH | EVOLENT HEALTH INC | United States | $3.15B | 115,430,107 | 89.64% | 10.36% | Net Selling | Net Selling |
| ZJYL | JIN MEDICAL INTERNATIONAL LTD | China | $580.80M | 160,000,000 | 0.00% | 0.00% | ||
| PSTX | POSEIDA THERAPEUTICS INC | United States | $267.27M | 96,489,127 | 46.85% | 40.59% | Net Selling | Net Selling |
| BNR | BURNING ROCK BIOTECH LTD | China | $76.63M | 102,440,448 | 19.65% | 0.00% | ||
| OCX | ONCOCYTE CORP | United States | $21.10M | 8,273,073 | 5.82% | 94.18% | Net Buying | Net Buying |
| CRVO | CERVOMED INC | United States | $149.14M | 6,170,479 | 0.47% | 99.53% | ||
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | United States | $2.12B | 251,399,871 | 35.06% | 64.94% | Net Selling | Net Selling |
| RDNT | RADNET INC | United States | $3.45B | 68,475,443 | 64.36% | 35.64% | Net Selling | |
| LGND | LIGAND PHARMACEUTICALS INC | United States | $1.26B | 17,705,287 | 14.99% | 85.01% | Net Selling | Net Buying |
Healthcare Industries
| Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 682 | +2.73% | +3.18% | -7.19% | -21.03% | 7.71x | 6.02x | -68.56% | +3.07% | +21.74% | +84.82% | Strong Buy | ||
| 66 | +0.70% | -0.56% | -6.06% | -2.35% | 38.50x | 4.18x | -22.82% | +6.39% | +10.99% | +11.35% | Buy | ||
| 17 | +0.52% | +3.18% | -0.94% | +13.75% | 151.40x | 6.24x | +34.95% | +8.30% | +14.47% | +13.15% | Buy | ||
| 90 | +0.48% | +3.46% | -1.40% | -6.22% | 32.65x | 2.12x | +11.34% | +2.71% | +5.06% | +33.93% | Strong Buy | ||
| 12 | -0.30% | -2.39% | -5.75% | -2.55% | 18.65x | 2.84x | +19.97% | +6.14% | +14.20% | +17.58% | Buy | ||
| 61 | +0.90% | -0.31% | -7.89% | -25.07% | 75.21x | 3.28x | +6.22% | +2.03% | +5.22% | +36.70% | Buy | ||
| 51 | +0.26% | -1.00% | -5.53% | +5.10% | -1.05x | 4.40x | -80.36% | +6.53% | +13.61% | +17.61% | Buy | ||
| 154 | +2.20% | +0.21% | -4.02% | -15.23% | 30.19x | 3.68x | +10.60% | +5.30% | +7.71% | +21.30% | Buy | ||
| 9 | -1.68% | -1.91% | -3.95% | +32.84% | 25.61x | 124.98x | -7.98% | +3.49% | +19.48% | +8.16% | Buy | ||
| 56 | +0.51% | +0.32% | -3.15% | -12.42% | 55.14x | 3.53x | +11.66% | +7.78% | +10.33% | +20.96% | Buy |
Healthcare Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.